Data from Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial
Authors:
- Mehmet A. BilenMBMehmet A. Bilen
- Brian I. RiniBRBrian I. Rini
- Martin H. VossMVMartin H. Voss
- James LarkinJLJames Larkin
- John B.A.G. HaanenJHJohn B.A.G. Haanen
- Laurence AlbigesLALaurence Albiges
- Lance C. PagliaroLPLance C. Pagliaro
- Eric G. VoogEVEric G. Voog
- Elaine T. LamELElaine T. Lam
- Nikolay KislovNKNikolay Kislov
- Bradley A. McGregorBMBradley A. McGregor
- Aly-Khan A. LalaniALAly-Khan A. Lalani
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)